Literature DB >> 22018986

NIRF is frequently upregulated in colorectal cancer and its oncogenicity can be suppressed by let-7a microRNA.

Feng Wang1, Peng Zhang, Yanlei Ma, Jianjun Yang, Mary Pat Moyer, Chenzhang Shi, Jiayuan Peng, Huanlong Qin.   

Abstract

Np95 ICBP90 RING finger (NIRF) is essential for the regulation of cell proliferation and has been implicated in tumorigenesis. However, the role of NIRF in colorectal cancer (CRC) remains unclear. In this study, we demonstrated that NIRF expression was aberrantly increased in CRC tissues and associated with poor overall survival. Bioinformatics analysis indicated that NIRF was a putative target of the microRNA let-7a, which was confirmed by luciferase reporter assay. We then demonstrated in vitro that enforced expression of let-7a, or knockdown of NIRF, led to reduced CRC cell proliferation due to cell cycle arrest at the G0/G1 phase and reduced cell migration. Finally, an in vivo tumorigenicity assay in nude mice showed that synthetic let-7a suppressed NIRF expression and reduced tumor growth. Taken together, our results provide new evidence that NIRF has an oncogenic role in CRC. This opens up the possibility of targeting NIRF and let-7a for CRC therapy.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22018986     DOI: 10.1016/j.canlet.2011.09.033

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  23 in total

1.  HBx promotes hepatocarcinogenesis by enhancing phosphorylation and blocking ubiquitinylation of UHRF2.

Authors:  Fengjuan Cheng; Guanhua Qian; Xianyun Fang; Jingjie Sun; Siyuan Chen; Rongjuan Chen; Shangjing Liu; Zhaodi Li; Kejia Wu; Shiming Jiang; Yong Chen; Ni Tang; Juan Chen; Changzhu Duan
Journal:  Hepatol Int       Date:  2021-04-19       Impact factor: 6.047

2.  Differential expression of serum miR-126, miR-141 and miR-21 as novel biomarkers for early detection of liver metastasis in colorectal cancer.

Authors:  Jie Yin; Zhigang Bai; Jianning Song; Yun Yang; Jin Wang; Wei Han; Jun Zhang; Hua Meng; Xuemei Ma; Yao Yang; Tingting Wang; Weirong Li; Zhongtao Zhang
Journal:  Chin J Cancer Res       Date:  2014-02       Impact factor: 5.087

3.  Multidimensional Proteomics Reveals a Role of UHRF2 in the Regulation of Epithelial-Mesenchymal Transition (EMT).

Authors:  Mi Lai; Lizhu Liang; Jiwei Chen; Naiqi Qiu; Sai Ge; Shuhui Ji; Tieliu Shi; Bei Zhen; Mingwei Liu; Chen Ding; Yi Wang; Jun Qin
Journal:  Mol Cell Proteomics       Date:  2016-04-25       Impact factor: 5.911

4.  Reciprocal regulation between microRNAs and epigenetic machinery in colorectal cancer.

Authors:  Feng Wang; Yanlei Ma; Huamin Wang; Huanlong Qin
Journal:  Oncol Lett       Date:  2017-01-11       Impact factor: 2.967

5.  UHRF2 promotes Hepatocellular Carcinoma Progression by Upregulating ErbB3/Ras/Raf Signaling Pathway.

Authors:  Jingjie Sun; Kejia Wu; Siyuan Chen; Shiming Jiang; Yong Chen; Changzhu Duan
Journal:  Int J Med Sci       Date:  2021-06-26       Impact factor: 3.738

6.  lncRNA NONRATT021972 siRNA Decreases Diabetic Neuropathic Pain Mediated by the P2X3 Receptor in Dorsal Root Ganglia.

Authors:  Haiying Peng; Lifang Zou; Jinyan Xie; Hong Wu; Bing Wu; Gaochun Zhu; Qiulan Lv; Xi Zhang; Shuangmei Liu; Guilin Li; Hong Xu; Yun Gao; Changshui Xu; Chunping Zhang; Shouyu Wang; Yun Xue; Shangdong Liang
Journal:  Mol Neurobiol       Date:  2016-01-07       Impact factor: 5.590

7.  An anti-let-7 sponge decoys and decays endogenous let-7 functions.

Authors:  Xiangling Yang; Zina Jeyapalan Rutnam; Chunwei Jiao; Duo Wei; Yizhen Xie; Jun Du; Ling Zhong; Burton B Yang
Journal:  Cell Cycle       Date:  2012-08-08       Impact factor: 4.534

8.  Expression of AQP5 and AQP8 in human colorectal carcinoma and their clinical significance.

Authors:  Wei Wang; Qing Li; Tao Yang; Guang Bai; Dongsheng Li; Qiang Li; Hongzhi Sun
Journal:  World J Surg Oncol       Date:  2012-11-13       Impact factor: 2.754

9.  miR-1 suppresses the growth of esophageal squamous cell carcinoma in vivo and in vitro through the downregulation of MET, cyclin D1 and CDK4 expression.

Authors:  Sen Jiang; Chao Zhao; Xiaodi Yang; Xiangyang Li; Qing Pan; Haijin Huang; Xuyang Wen; Husheng Shan; Qianwen Li; Yunxiang Du; Yaping Zhao
Journal:  Int J Mol Med       Date:  2016-05-31       Impact factor: 4.101

10.  MicroRNAs as Novel Biomarkers in Colorectal Cancer.

Authors:  Sonja Hrašovec; Damjan Glavač
Journal:  Front Genet       Date:  2012-10-19       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.